Literature DB >> 30454957

Association between affective disorders presenting before and during pregnancy and pre-term birth, considering socio-demographic factors, obstetric factors, health conditions, and use of medication.

Arantxa Aliaga1, Oriol Cunillera2, María Del Carmen Amador3, Mercedes Aliaga4, Martí Arquerons5, Jesús Almeda6.   

Abstract

OBJECTIVE: To study the relationship between maternal affective disorders (AD) before and during pregnancy, and pre-term birth.
DESIGN: Retrospective observational study. LOCATION: Sexual and reproductive health units at the Institut Català de la Salut (ICS) in Catalonia, Spain. PARTICIPANTS: Pregnant women with a result of live-born child from 1/1/2012 to 30/10/2015.
INTERVENTIONS: Data were obtained from the ICS Primary Care electronic medical record. MAIN MEASUREMENTS: Diagnosis of AD before and during pregnancy, months of pregnancy, and possible confusion factors were collected. Descriptive statistical analysis (median, interquartile range, and absolute and relative frequency), bivariate analysis (Wilcoxon test and Chi-square test), and multivariate analysis (logistic regression) were performed.
RESULTS: 102,086 women presented valid information for the study. Prevalence of AD during pregnancy was 3.5% (4.29% in pre-term and 3.46% in term births; p<0.004). Pregnant women with pre-term births presented a higher age, smoking habit, lower inter-pregnancy interval, and a lower socio-economic status. Pre-term birth was significantly associated to previous history of stress and dissociative disorder (SDD), anxiety, obsessive-compulsive disorder (OCD) and eating disorders (ED), and use of antidepressants. It was also associated to abuse of alcohol, smoking, and use of psychoactive substances, as well as SDD, ED, use of antipsychotics, and divorce during pregnancy. Multivariate analysis confirmed the relationship between pre-term birth and history of AD, SDD, ED, and smoking, but not with AD during pregnancy.
CONCLUSIONS: Examining the previous history of SDD and ED in pregnant women, and SDD, and ED during pregnancy is highly relevant to avoid pre-term birth.
Copyright © 2018 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Affective disorders; Antidepresivos; Antidepressive agents; Embarazo; Factores de riesgo; Infant; Pregnancy; Premature; Recién nacido Prematuro; Risk factors; Trastornos psicóticos afectivos

Mesh:

Substances:

Year:  2018        PMID: 30454957      PMCID: PMC6930948          DOI: 10.1016/j.aprim.2018.06.009

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


Introduction

Depression is the most frequent mental disorder in women. It may alter the course of pregnancy, affect the foetus, and the newborn, having consequences even on adolescence.1, 2 Prevalence of depression during pregnancy ranges from 4.8% to 33.2%, with under 50% of cases identified in the everyday clinical practice. Depression and bipolar disorder have been associated to pre-term birth.5, 6, 7, 8, 9, 10 Studies on the relationship between affective disorders and pre-term birth, conducted in the Mediterranean and South European countries, and included in systematic reviews, are scarce, therefore, no data on this matter are available in our country. Pre-term birth has been associated to prolonged stays at paediatric intensive care units or neonatal departments, a higher incidence of infection, and of respiratory, digestive, ophthalmologic, psychomotor conditions, etc., resulting in a remarkable impact on the health care system. Other clinical obstetric and therapeutic factors associated to pre-term birth are collected on the Clinical Practice Guideline for care in Pregnancy and Puerperium in the Spanish National Health Service (NHS), on the ‘Protocol de Seguiment de l’embaràs a Catalunya’ (Protocol on pregnancy monitoring in Catalonia), and on numerous publications14, 15 (Table S1). Moreover, pre-term birth has been associated with stress,16, 17 and low socio-economic status. The Spanish NHS guideline systematically evaluates postpartum depression, but it does not recommend a similar population screening during pregnancy, unlike other countries. It neither recommends a systematic mental health examination on women of childbearing age. The current study aims to study the relationship between maternal affective disorders (AD) and pre-term birth, controlling by the confusion factors associated to pre-term birth, and differentiating between those factors which appeared priorly, and those presenting during pregnancy. Since mental health disorders are not as extensively investigated as physical conditions, on the patient anamnesis performed on women in family and maternal and child primary healthcare services, we will dedicate special attention to them. This study is framed within the primary healthcare area, being its implementation necessary since to date, no similar clinical study has been performed in our country. The aim is to study the relationship between maternal affective disorders (AD) before and during pregnancy, and pre-term birth.

Material and methods

Design, area of study, and research subjects

Retrospective observational study conducted in the primary health care area. Data were obtained from the Information System for the Enhancement of Research in Primary Care (SIDIAP) database, with an assigned population in 2012 of 5,835,000 patients (80% of the total population in Catalonia). This database is supplied, among other, by information from the Primary Care electronic medical records (e-CAP), and from the Sexual and Reproductive Health Care Program (ASSIR) of the Catalan Institute of Health (ICS), used by obstetricians, gynaecologists, and midwives in primary care. The ASSIR records include data on pregnancy, delivery, and postpartum monitoring from women who attended the primary health care services of the ICS, accounting for 65.7% term pregnancies in Catalonia, over the period of our study. All pregnant women registered in the SIDIAP, aged 15–47, who gave birth to live-born children in Catalonia from 1st January 2012 to 30 October 2015, with a gestational age over 25 weeks and under 44 weeks, and with two foetuses at most, were included in the study.

Variables

Pre-term birth was defined as gestational age under 37 weeks, based on the number of days from the date of last menstruation to the date of birth. AD included the following ICD-10 codes: F30 (Manic episode), F31 (Bipolar disorder), F32 (Depressive disorders), F33 (Recurrent depressive disorder), F34 (Persistent mood affective disorder), F38 (Other mood affective disorders), F39 (Unspecified mood affective disorders), presenting before pregnancy (at any time of life) or during pregnancy. Socio-economic status was classified according to the Deprivation index MEDEA, presented in quintiles (the highest quintile, the lower socio-economic status). All the variables related to pre-term birth found on the clinical guides, and on the conducted bibliographic search, were collected7, 12, 13, 14, 15, 16, 17 (Table S1). Considering the ICD-10,099 code includes all mental disorders, those most discussed and controverted on the reviewed literature, were chosen. Those AD interrelated, especially when scarce in number, were gathered, namely, stress and dissociative disorder (SDD), eating disorder (ED), anxiety disorder, obsessive compulsive disorder (OCD), etc. Whether these diagnoses were active before or during pregnancy was taken into consideration. Finally, all treatments related to pre-term birth, based on clinical guides and literature, were registered, and coded according to the “Anatomical Therapeutic Chemical Classification” (WHOCC-ATC) (Table S2). It was also recorded whether medication was taken before or during pregnancy.

Statistical analysis

Descriptive statistical analysis, showing median and interquartile range for numeric variables, and absolute and relative frequency for categorical variables; A bivariate analysis according to pre-term birth, was performed, through Wilcoxon test for numeric variables and Chi-square test for categorical variables. A multivariate logistic regression model was built (final model obtained by an AIC stepwise backwards variable selection model from all statistically and clinically relevant variables on the bivariate analysis), without including possible interactions between them. All analyses were conducted by complete case (without missing values being treated). Significance level of 0.05 was considered as indicator of statistically significant differences. Treatment of data and statistical analyses were performed using software R 3.2.4-revised. Study schema. Retrospective observational study with the aim to investigate the relationship between maternal affective disorders (AD) before and during pregnancy, and pre-term birth.

Results

Out of the 119,036 pregnancies which fulfilled the inclusion criteria, valid information for the study was obtained from 102,086 women (85%). The prevalence of affective disorders during pregnancy was 3.5%, and the prevalence of pre-term birth 4.2%. Patients who presented pre-term birth showed a significantly higher age, a lower socio-economic status, a higher history of previous pre-term birth, a higher history of abortion, a shorter interval between pregnancies, and a higher rate of twin pregnancies (Table 1). Pre-term birth was also significantly associated with history of AD, OCD, SDD, smoking, and ED, among other (Table 2).
Table 1

Descriptive global and bivariate analysis of maternal characteristics, previous pregnancies, and labour regarding preterm birth.

N = 102,086MissingGlobal (n = 102,086)Normal (n = 97,800)Preterm (n = 4,286)p-Value
Socio-demographic characteristics
 Agea031.00 [27.00, 35.00]31.00 [27.00, 35.00]32.00 [28.00, 36.00]<0.001
 MEDEA deprivation index00.038
 Rural15,487 (15.17%)14,804 (15.14%)683 (15.94%)
 Quintile 1 (less disadvantaged)9,553 (9.36%)9,188 (9.39%)365 (8.52%)
 Quintile 224,866 (24.36%)23,864 (24.40%)1,002 (23.38%)
 Quintile 314,508 (14.21%)13,913 (14.23%)595 (13.88%)
 Quintile 417,236 (16.88%)16,514 (16.89%)722 (16.85%)
 Quintile 5 (more disadvantaged)20,436 (20.02%)19,517 (19.96%)919 (21.44%)
 Partnership status00.468
 Single37,279 (36.52%)35,691 (36.49%)1,588 (37.05%)
 Partner64,807 (63.48%)62,109 (63.51%)2,698 (62.95%)



Previous delivery
 Term deliveryb1,3341.07 (1.01)1.08 (1.01)0.81 (0.99)<0.001
 Preterm deliveryb1,3340.03 (0.19)0.02 (0.16)0.22 (0.52)<0.001
 Abortionb1,3340.46 (0.79)0.46 (0.79)0.53 (0.88)<0.001
 Live bornb1,3341.08 (1.01)1.09 (1.00)0.98 (1.02)<0.001
 Inter-pregnancy interval0<0.001
 (>18 months)85,813 (84.06%)82,292 (84.14%)3,521 (82.15%)
 [12–18] months5,334 (5.23%)5,102 (5.22%)232 (5.41%)
 [0–12] months10,939 (10.72%)10,406 (10.64%)533 (12.44%)



Delivery characteristics
 Type14,439<0.001
 Eutocic56,808 (64.81%)54,974 (65.36%)1,834 (51.81%)
 Dystocic30,839 (35.19%)29,133 (34.64%)1,706 (48.19%)
 Number of foetuses0<0.001
 1100,624 (98.57%)96,872 (99.05%)3,752 (87.54%)
 21,462 (1.43%)928 (0.95%)534 (12.46%)

Qualitative variables are expressed in absolute and relative frequency for each category, and numeric variables are expressed in (a) median and interquartile range, or (b) media and standard deviation. Variable distribution between preterm and term labour groups is compared by Wilcoxon test for numeric variables, and Chi-square test for categorical variables.

Table 2

[ll1]Health conditions before birth. Descriptive and bivariate analysis according to preterm birth.

Previous history
During pregnancy
GlobalNormal (n = 97,800)Preterm (n = 4,286)p-ValueGlobalNormal (n = 97,800)Preterm (n = 4,286)p-Value
Affective disorder1,631 (1.60%)1,533 (1.57%)98 (2.29%)<0.0013,571 (3.50%)3,387 (3.46%)184 (4.29%)0.004
Anxiety disorder and obsessive-compulsive disorder6,775 (6.64%)6,427 (6.57%)348 (8.12%)<0.00114,996 (14.69%)14,294 (14.62%)702 (16.38%)0.002
Dissociative and stress disorder746 (0.73%)695 (0.71%)51 (1.19%)<0.0011,922 (1.88%)1,818 (1.86%)104 (2.43%)0.009
Smoker7,962 (7.80%)7,623 (7.79%)339 (7.91%)0.80622,533 (22.07%)21,491 (21.97%)1,042 (24.31%)<0.001
Non-smoker2,455 (2.40%)2,372 (2.43%)83 (1.94%)0.04647,962 (46.98%)46,045 (47.08%)1,917 (44.73%)0.003
Mental and behavioural disorders due to use of tobacco2,869 (2.81%)2,756 (2.82%)113 (2.64%)0.51115,961 (15.63%)15,217 (15.56%)744 (17.36%)0.002
Eating disorder207 (0.20%)192 (0.20%)15 (0.35%)0.044833 (0.82%)803 (0.82%)30 (0.70%)0.438
Mental and behavioural disorders due to use of psychoactive substances125 (0.12%)120 (0.12%)5 (0.12%)1.000451 (0.44%)422 (0.43%)29 (0.68%)0.024
Mental and behavioural disorders due to use of alcohol69 (0.07%)63 (0.06%)6 (0.14%)0.118277 (0.27%)250 (0.26%)27 (0.63%)<0.001
Divorce287 (0.28%)275 (0.28%)12 (0.28%)1.0001,468 (1.44%)1,387 (1.42%)81 (1.89%)0.013
In Vitro fertilization147 (0.14%)135 (0.14%)12 (0.28%)0.028573 (0.56%)503 (0.51%)70 (1.63%)<0.001
Caesarean1,033 (1.01%)973 (0.99%)60 (1.40%)0.012334 (0.33%)322 (0.33%)12 (0.28%)0.677
Twin pregnancy39 (0.04%)36 (0.04%)3 (0.07%)0.491169 (0.17%)114 (0.12%)55 (1.28%)<0.001
Placental pathology13 (0.01%)12 (0.01%)1 (0.02%)1.00023 (0.02%)19 (0.02%)4 (0.09%)0.008
Placenta praevia, detachment, antepartum haemorrhage780 (0.76%)752 (0.77%)28 (0.65%)0.4462,623 (2.57%)2,413 (2.47%)210 (4.90%)<0.001
Pre-eclampsia-Eclampsia417 (0.41%)383 (0.39%)34 (0.79%)<0.0011,046 (1.02%)892 (0.91%)154 (3.59%)<0.001
Hypertension110 (0.11%)101 (0.10%)9 (0.21%)0.065852 (0.83%)751 (0.77%)101 (2.36%)<0.001
Glomerular disease, tubulo-interstitial disease, lithiasis, other1,432 (1.40%)1,366 (1.40%)66 (1.54%)0.4751,608 (1.58%)1,524 (1.56%)84 (1.96%)0.045
Metabolic disorder310 (0.30%)293 (0.30%)17 (0.40%)0.3233,829 (3.75%)3,603 (3.68%)226 (5.27%)<0.001
Viral Hepatitis270 (0.26%)249 (0.25%)21 (0.49%)0.005769 (0.75%)735 (0.75%)34 (0.79%)0.827
Diabetes Mellitus49 (0.05%)44 (0.04%)5 (0.12%)0.082372 (0.36%)333 (0.34%)39 (0.91%)<0.001
Toxic liver disease5 (0.00%)3 (0.00%)2 (0.05%)0.0048 (0.01%)7 (0.01%)1 (0.02%)0.772
Sexual transmission disease251 (0.25%)233 (0.24%)18 (0.42%)0.028789 (0.77%)761 (0.78%)28 (0.65%)0.410
Viral disease14,230 (13.94%)13,577 (13.88%)653 (15.24%)0.0135,219 (5.11%)4,982 (5.09%)237 (5.53%)0.218
Mycosis (Aspergillus, etc.)47 (0.05%)46 (0.05%)1 (0.02%)0.73196 (0.09%)86 (0.09%)10 (0.23%)0.005
Blood disorder58 (0.06%)52 (0.05%)6 (0.14%)0.045479 (0.47%)459 (0.47%)20 (0.47%)1.000
Congenital malformation126 (0.12%)119 (0.12%)7 (0.16%)0.5911,127 (1.10%)1,062 (1.09%)65 (1.52%)0.010
Cerebral palsy and other4 (0.00%)4 (0.00%)0 (0.00%)1.00029 (0.03%)25 (0.03%)4 (0.09%)0.035
Vestibular disorder2325 (2.28%)2,208 (2.26%)117 (2.73%)0.0481,220 (1.20%)1,165 (1.19%)55 (1.28%)0.638
Benign tumoura493 (0.48%)452 (0.46%)41 (0.96%)<0.0012319 (2.27%)2,198 (2.25%)121 (2.82%)0.015
Tumour37 (0.04%)35 (0.04%)2 (0.05%)1.000113 (0.11%)102 (0.10%)11 (0.26%)0.007

Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous.

Absolute and relative frequency of women presenting the characteristic are shown for each variable. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on variables prior to pregnancy (previous history) and variables during pregnancy.

Descriptive global and bivariate analysis of maternal characteristics, previous pregnancies, and labour regarding preterm birth. Qualitative variables are expressed in absolute and relative frequency for each category, and numeric variables are expressed in (a) median and interquartile range, or (b) media and standard deviation. Variable distribution between preterm and term labour groups is compared by Wilcoxon test for numeric variables, and Chi-square test for categorical variables. [ll1]Health conditions before birth. Descriptive and bivariate analysis according to preterm birth. Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous. Absolute and relative frequency of women presenting the characteristic are shown for each variable. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on variables prior to pregnancy (previous history) and variables during pregnancy. With regard to health conditions during pregnancy (Table 2), pre-term birth was bivariately associated with anxiety, OCD, AD, SDD, divorce, smoking, mental disorder due to psychoactive substance use, abuse of alcohol and tobacco, among other. It was also associated with history of antidepressant intake and use of antipsychotics during pregnancy, among other (Table 3).
Table 3

Use of medication prior to birth. Descriptive and bivariate analysis according to preterm birth.

Previous history
During pregnancy
Global (n = 102,086)Normal (n = 97,800)Preterm (n = 4,286)p-ValueGlobal (n = 102,086)Normal (n = 97,800)Preterm (n = 4,286)p-value
Anticoagulants3,548 (3.48%)3,385 (3.46%)163 (3.80%)0.2491,770 (1.73%)1,578 (1.61%)192 (4.48%)<0.001
Antidepressants11,529 (11.29%)10,962 (11.21%)567 (13.23%)<0.0014,143 (4.06%)3,936 (4.02%)207 (4.83%)0.010
Androgens21,109 (20.68%)20,253 (20.71%)856 (19.97%)0.2529,125 (8.94%)8,589 (8.78%)536 (12.51%)<0.001
Antipsychotics2,179 (2.13%)2,070 (2.12%)109 (2.54%)0.066407 (0.40%)374 (0.38%)33 (0.77%)<0.001
ACEI382 (0.37%)337 (0.34%)45 (1.05%)<0.001191 (0.19%)160 (0.16%)31 (0.72%)<0.001
Progestagens18,744 (18.36%)17,993 (18.40%)751 (17.52%)0.1538,191 (8.02%)7,704 (7.88%)487 (11.36%)<0.001

Absolute and relative frequency of use, are shown for each medication. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on use of medication prior to pregnancy (previous history) and during pregnancy.

ACEI = angiotensin converting enzyme inhibitors.

Use of medication prior to birth. Descriptive and bivariate analysis according to preterm birth. Absolute and relative frequency of use, are shown for each medication. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on use of medication prior to pregnancy (previous history) and during pregnancy. ACEI = angiotensin converting enzyme inhibitors. Pre-term birth was significantly associated with history of AD, SDD, ED, and smoking among other, in the final multivariate model. It was also associated with presence of smoking and mental disorder due to use of alcohol during pregnancy, among other (Table 4). The association between AD before pregnancy and pre-term birth, in terms of punctual estimation of the adjusted OR (1.32 95%CI: [1.04, 1.64]) was inferior than Eclampsia (3.22 [2.63, 3.90]), DM (2.31 [1.56, 3.31]), and HTA (2.15 [1.64, 2.79]) and Placenta praevia, detachment, antepartum haemorrhage (1.80 [1.53, 2.11]), and superior than smoking (non-smokers OR: 0.92 [0.86, 0.98]). Presence of SDD during pregnancy was relevant, providing plausibility to the model, although its marginal effect did not reach statistical significance. Association between AD during pregnancy and pre-term birth was not statistically significant.
Table 4

Multivariate analysis on health conditions prior and during pregnancy and preterm birth.

Odds Ratio [CI95%]p-Value
  (Independent term)0.00 [0.00, 0.00]<0.001
Affective disorders during pregnancy1.07 [0.90, 1.26]0.413
 Previous births characteristicsTerm birth0.54 [0.45, 0.63]<0.001
Preterm birth4.68 [4.00, 5.45]<0.001
Abortion1.07 [1.03, 1.11]0.001
Live-born1.44 [1.21, 1.71]<0.001
 Socio-economic statusRural-reference-
Quintile 1 (less disadvantaged)0.92 [0.80, 1.05]0.231
Quintile 20.92 [0.82, 1.02]0.117
Quintile 30.91 [0.81, 1.03]0.144
Quintile 40.98 [0.88, 1.10]0.789
Quintile 5 (more disadvantaged)1.09 [0.97, 1.21]0.136
 Inter-pregnancy intervalWithout short interval-reference-
12 to 18 months0.98 [0.84, 1.14]0.822
Under 12 months1.19 [1.07, 1.32]<0.001
 Number of foetuses14.32 [12.37, 16.55]<0.001



Previous history
 Affective disorder1.32 [1.04, 1.64]0.017
 Dissociative and stress disorder1.41 [1.02, 1.91]0.030
 Non-smoker0.72 [0.56, 0.91]0.007
 Eating disorder1.91 [1.05, 3.20]0.022
 Viral Hepatitis1.79 [1.04, 2.90]0.025
 Toxic liver disease12.75 [1.53, 83.93]0.009
 Benign tumoura1.70 [1.18, 2.38]0.003



During pregnancy
 Medication
  Anticoagulants1.39 [1.15, 1.67]<0.001
  Androgens1.23 [1.10, 1.36]<0.001
  Antipsychotics1.61 [1.05, 2.36]0.021
  ACEI1.88 [1.13, 3.03]0.012



 Health conditions
  Dissociative and stress disorder1.24 [0.99, 1.53]0.051
  Non-smoker0.92 [0.86, 0.98]0.010
  Mental and behavioural disorders due to use of alcohol1.92 [1.20, 2.93]0.004
  In Vitro fertilization1.46 [1.05, 2.00]0.021
  Placenta praevia, detachment, antepartum haemorrhage1.80 [1.53, 2.11]<0.001
  Eclampsia3.22 [2.63, 3.90]<0.001
  Hypertension2.15 [1.64, 2.79]<0.001
  Glomerular disease, tubulo-interstitial disease, lithiasis, other1.20 [0.94, 1.52]0.128
  Metabolic disorder1.30 [1.11, 1.51]<0.001
  Diabetes Mellitus2.31 [1.56, 3.31]<0.001
  Mycosis (Aspergillus, etc.)3.35 [1.60, 6.26]<0.001
  Congenital malformation1.24 [0.94, 1.61]0.122
  Cerebral palsy and other2.72 [0.74, 7.74]0.088
  Tumour2.38 [1.12, 4.51]0.014

Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous.

ACEI = angiotensin converting enzyme inhibitors.

Results of the multivariate logistic regression model on preterm birth. Final model obtained by “stepwise backwards” variable selection model based on the “Akaike Information Criteria” from all statistically significant and clinically relevant variables on the bivariate analysis, as explicative variables. Results are presented in “Odds Ratio”, with a confidence interval of 95%, estimated as the exponential of the obtained coefficient from the multivariate logistic regression model, and p-value of its statistical significance.

Multivariate analysis on health conditions prior and during pregnancy and preterm birth. Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous. ACEI = angiotensin converting enzyme inhibitors. Results of the multivariate logistic regression model on preterm birth. Final model obtained by “stepwise backwards” variable selection model based on the “Akaike Information Criteria” from all statistically significant and clinically relevant variables on the bivariate analysis, as explicative variables. Results are presented in “Odds Ratio”, with a confidence interval of 95%, estimated as the exponential of the obtained coefficient from the multivariate logistic regression model, and p-value of its statistical significance.

Discussion

This study shows an association between previous history of maternal AD and pre-term birth. The prevalence of pre-term birth obtained in our study was 4.2%, lower than the 7% expected. This may have been due to the restrictive inclusion criteria considered in the study, and to the fact that in 2012 not all ASSIR relied on the same electronic register. The prevalence of AD during pregnancy obtained in our study is considerably lower than that published on most studies which use depression scales without diagnostic confirmation (often self-reported),3, 4 being comparable to that reported in studies which use clinical diagnoses, and even to that found in studies performed in psychiatric in-patient wards. Most widely used health evaluation instruments present sensitivity and specificity values which are far from ideal. Therefore, the ‘Edinburgh Postnatal Depression Scale’ (EPDS) shows a sensitivity of 0.72 and a specificity of 0.85 for the 10 cut-off point for ‘minor’ or ‘major depression’ on the English version, and 0.81 and 0.92 respectively, on the non-English versions; The sensitivity and specificity values for the ‘Patient Health Questionnaire’ (PHQ) are 0.79 and 0.75 respectively. Accordingly, the use of this type of screening tools -with specificity far from ideal- to screen population for low prevalence conditions automatically triggers prevalence values. Whereas the definition of AD, would lead one to expect a higher prevalence than that found in those studies limited to depression (most of them), it is to be expected a lower prevalence of AD in the population seen in primary care (general population) than in the population seen in specialized centres. Despite identifying a bivariate association between AD during pregnancy and pre-term birth initially, we did not observe this association on the multivariate analysis, after considering history of AD (prior to pregnancy), and other factors like the use of relevant medication, whose bivariate association with pre-term birth had also resulted significant. These results contradict the findings of the two meta-analysis published on this matter23, 24; although the authors themselves recognize their studies’ limitations: Grigoriadis concluded that the association was modest and the quality of evidence insufficient, and Grote reported lack of homogeneity among the evaluated studies. Both considered significantly fewer confusion factors than our work, which may explain this assumed difference. However, our findings are consistent with more recent publications: Mei-Danobserved an association between history of maternal AD and pre-term birth, after comparing pregnant women who had been hospitalized due to bipolar disorder or major depression within the 5 years prior to pregnancy, with those without documented history of mental disorder. We consider that the higher the diagnostic specificity, the stronger this association becomes. Furthermore, Mannisto, observed an association between pre-term birth and maternal depression or bipolar disorder, based on electronic medical records and maternal psychiatric diagnoses from discharge summaries. Räisänen found a significant association between depression and pre-term birth, being smoking a relevant contributing factor, and history of depression prior to pregnancy the risk factor with the strongest association. On the other hand, considering the generalized concept that prevalence of depression may be lower in the Mediterranean area, since our study was conducted in a Spanish population, we may expect a lower rate of AD than that found in North European or North American populations. However, last report from the WHO contradicts this assumption, having reported a higher relevance of low socio-economic status on the prevalence of this disorder, regardless of the country in which the study was conducted. Our work includes a population from all socio-economic status, which may explain the lower prevalence of depression, and is novel since addresses pregnant women resident in Catalonia. Some authors have observed association between low socio-economic status (LSES) and situations of chronic stress, and between both with depression and pre-term birth.16, 17 In our study both LSES and diagnosis of SDD were associated to pre-term birth in the bivariate analysis. Multivariate analysis showed association between previous history of SDD and pre-term birth; however, the association of SDD during pregnancy with pre-term birth was not statistically significant, although by a very small margin. Most authors underline the relevance of identifying and alleviating exposure to stress during pregnancy, as far as possible, to reduce pre-term birth; our results demonstrate the importance of evaluating the presentation of these disorders prior to pregnancy. With regards to use of antidepressants, two meta-analysis recently conducted on the antidepressant-pre-term birth association, Huang and Eke,27, 28 considering exclusively selective serotonin reuptake inhibitors (SSRIs), found an association between the use of SSRIs and pre-term birth. Viktorin, just observed a small reduction in gestational age associated to SSRIs. Sujan published in 2017 a retrospective cohort study, in which association between use of antidepressants, in general, during the first trimester of pregnancy and pre-term birth was observed. Our results, considering all antidepressants – except mood stabilizers-are consistent with these findings in the bivariate analysis, although do not coincide in the multivariate analysis. This discrepancy suggests the need to conduct further studies on the effect of the various antidepressant drugs on pre-term birth. With reference to the relationship between use of antipsychotic medication during pregnancy and pre-term birth, we observed a statistically significant association, consistent with the findings of Galbally. It seems sensible to follow the general tendency to evaluate the risk-benefit relationship of using this medication in the pregnant woman who needs it, thoroughly and individually. One of the limitations of this study is the possible existence of incorrect or unregistered diagnoses, inherent to the use of electronic medical. In primary care settings, the data are entered by general practitioners, due to their own diagnosis, or because they have seen it in specialist reports or hospital discharge reports (in these last two cases the data are not downloaded automatically in the computerized records of primary care, with the consequent delay in the coding of hospital and specialist diagnoses). This can also ignore the diagnoses made in private care and not seen in primary care. And finally, it is also of note that data obtained from ASSIR of 2012 were incomplete, as the ASSIR electronic medical records were not homogeneous then. Although the big sample size and representativeness of the study is an important strength, it must be advised that it can affect to the statistical signification of tests, easily leading to significance. Nevertheless (and keeping that in mind when valuing p-values), multivariate regression model was selected according to Akaike Information Criteria, and variables were included or not in the final model with disregard of their p-values. On the other hand, our multivariate analysis only took into account the effect of the independent variables without interaction among them; since being such a large number, made it practically impossible to examine all variables two by two. Due to the exploratory nature of the study, it was considered inadequate to force a hypothesis on a limited number of possible interactions. Nevertheless, the SIDIAP data base has been widely validated. Unlike other data bases, all primary care professionals in the ICS participate in it, not only voluntaries; and benefits from a first-rate anonymity system, which can open the way to conduct further research in our line, and in other areas where similar data bases – which include most of the population treated in the primary healthcare – may be established. In conclusion, a previous history of AD in pregnant women is associated to pre-term birth. Classically, general habits and physical conditions have received more attention when evaluating health in pregnancy. This study demonstrates that, at least regarding avoiding pre-term birth and its severe consequences, to investigate the history of affective disorders, and the psychosocial environment in the pregnant woman is of great relevance, considering the potential stressful situations which may affect the course of pregnancy. We coincide with some authors in that the aforementioned should be explored within a general examination, in a trusted environment, within the framework of the appropriate physician-patient relationship in primary care; paying attention to avoid that the patient may feel stigmatized or fear social services intervention. This becomes easier if we regard that any women of childbearing age can be a mother, and establish this desirable relationship from adolescence, whenever possible. A thorough anamnesis, which includes psychosocial factors – like the already available in many primary care devices, which have not received the attention they deserve – is undoubtedly, a suitable instrument to perform this task.

Key Points

The known on the subject:

Depression is the most frequent mental disorder in women and it may alter the course of pregnancy, affect the foetus, and the newborn. Studies on the relationship between affective disorders and pre-term birth are scarce, therefore, and few data on this matter are available in our country. The Spanish NHS guideline systematically evaluates postpartum depression, but it does not recommend a similar population screening during pregnancy, unlike other countries.

What does this study contribute?

This study shows an association between previous history of maternal affective disorders and pre-term birth. To investigate the history of affective disorders, and the psychosocial environment in the pregnant woman is of great relevance, considering the potential stressful situations which may affect the course of pregnancy and avoiding pre-term birth and its severe consequences. A thorough anamnesis, which includes psychosocial factors – like the already available in many primary care devices, which have not received the attention they deserve – is undoubtedly, a suitable instrument to perform this task.

Funding

This study received a research grant from the SIDIAP (Information System for the Enhancement of Research in Primary Care) of the University Institute for Research in Primary Care (IDIAP) Jordi Gol, in its 4th call for 2014.

Conflict of interest

The authors declare that there is no conflict of interest regarding the publication of this article.
  24 in total

1.  [SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research].

Authors:  Bonaventura Bolíbar; Francesc Fina Avilés; Rosa Morros; Maria del Mar Garcia-Gil; Eduard Hermosilla; Rafael Ramos; Magdalena Rosell; Jordi Rodríguez; Manuel Medina; Sebastian Calero; Daniel Prieto-Alhambra
Journal:  Med Clin (Barc)       Date:  2012-03-22       Impact factor: 1.725

2.  [Constructing a deprivation index based on census data in large Spanish cities(the MEDEA project)].

Authors:  M Felícitas Domínguez-Berjón; Carme Borrell; Gemma Cano-Serral; Santiago Esnaola; Andreu Nolasco; M Isabel Pasarín; Rebeca Ramis; Carme Saurina; Antonio Escolar-Pujolar
Journal:  Gac Sanit       Date:  2008 May-Jun       Impact factor: 2.139

3.  Depression and anxiety in women during pregnancy and neonatal outcome: data from the EDEN mother-child cohort.

Authors:  Gladys Ibanez; Marie-Aline Charles; Anne Forhan; Guillaume Magnin; Olivier Thiebaugeorges; Monique Kaminski; Marie-Josèphe Saurel-Cubizolles
Journal:  Early Hum Dev       Date:  2012-02-22       Impact factor: 2.079

Review 4.  Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Authors:  A C Eke; G Saccone; V Berghella
Journal:  BJOG       Date:  2016-05-30       Impact factor: 6.531

5.  Perinatal outcomes among women with bipolar disorder: a population-based cohort study.

Authors:  Elad Mei-Dan; Joel G Ray; Simone N Vigod
Journal:  Am J Obstet Gynecol       Date:  2014-10-15       Impact factor: 8.661

6.  Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age.

Authors:  Alexander Viktorin; Paul Lichtenstein; Cecilia Lundholm; Catarina Almqvist; Brian M D'Onofrio; Henrik Larsson; Mikael Landén; Patrik K E Magnusson
Journal:  Int J Epidemiol       Date:  2016-01-09       Impact factor: 7.196

Review 7.  Primary Care Screening for and Treatment of Depression in Pregnant and Postpartum Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Elizabeth O'Connor; Rebecca C Rossom; Michelle Henninger; Holly C Groom; Brittany U Burda
Journal:  JAMA       Date:  2016-01-26       Impact factor: 56.272

8.  Psychosocial stress during pregnancy is related to adverse birth outcomes: results from a large multi-ethnic community-based birth cohort.

Authors:  Eva M Loomans; Aimée E van Dijk; Tanja G M Vrijkotte; Manon van Eijsden; Karien Stronks; Reinoud J B J Gemke; Bea R H Van den Bergh
Journal:  Eur J Public Health       Date:  2012-07-31       Impact factor: 3.367

9.  Identification of depression in women during pregnancy and the early postnatal period using the Whooley questions and the Edinburgh Postnatal Depression Scale: protocol for the Born and Bred in Yorkshire: PeriNatal Depression Diagnostic Accuracy (BaBY PaNDA) study.

Authors:  Elizabeth Littlewood; Shehzad Ali; Pat Ansell; Lisa Dyson; Samantha Gascoyne; Catherine Hewitt; Ada Keding; Rachel Mann; Dean McMillan; Deborah Morgan; Kelly Swan; Bev Waterhouse; Simon Gilbody
Journal:  BMJ Open       Date:  2016-06-13       Impact factor: 2.692

10.  Effect of maternal stress during pregnancy on the risk for preterm birth.

Authors:  Caroline Lilliecreutz; Johanna Larén; Gunilla Sydsjö; Ann Josefsson
Journal:  BMC Pregnancy Childbirth       Date:  2016-01-15       Impact factor: 3.007

View more
  2 in total

1.  Transfer of brotizolam, periciazine, and sulpiride in cord blood and breast milk, and alprazolam in breast milk: a case report.

Authors:  Jumpei Saito; Yoshiyuki Tachibana; Yuka Sano Wada; Naho Yakuwa; Hiroyo Kawasaki; Tomo Suzuki; Haruhiko Sago; Akimasa Yamatani; Atsuko Murashima
Journal:  J Pharm Health Care Sci       Date:  2022-04-01

2.  Perception of the Body Image in Women after Childbirth and the Specific Determinants of Their Eating Behavior: Cross-Sectional Study (Silesia, Poland).

Authors:  Mateusz Grajek; Karolina Krupa-Kotara; Martina Grot; Maria Kujawińska; Paulina Helisz; Weronika Gwioździk; Agnieszka Białek-Dratwa; Wiktoria Staśkiewicz; Joanna Kobza
Journal:  Int J Environ Res Public Health       Date:  2022-08-16       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.